Reporting an Adverse Event: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Health Products Regulatory Authority (HPRA) Pharmacovigilance. www.hpra.ie.

This website is intended for Healthcare Professionals working in Ireland

Copyright© 2025 AbbVie Inc.

Unless otherwise specified, all product names appearing in this internet site are trademarks owned or licensed by AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade names or trade dress in this site may be made without the prior written authorisation of AbbVie Inc., except to identify the product or services of the company

AbbVie Pro is developed and funded by AbbVie Limited

AbbVie Limited, a private company limited by Shares, and a member of the AbbVie group of companies.

Registered in Ireland with Company Number 510846.

Local contact details: 14 Riverwalk, Citywest Business Campus, Dublin 24, D24 XN32, Ireland. Tel (0) 1 4287900. www.abbvie.ie

Date of Preparation: October 2025 | IE-ABBV-220078